Blue Origin has been granted permission to resume space flights following the accident

Blue Origin has received FAA approval to resume launches of its New Glenn heavy-lift rocket after a month-long hold following an April upper-stage thermal failure that prevented an AST SpaceMobile satellite from reaching orbit. The booster’s first re-flight and second successful ocean landing support the company’s reusability efforts, while the failed payload loss was covered by insurance. The company still plans up to 12 New Glenn launches this year, though the temporary suspension may affect timing.

Analysis

This clearance is a positive read-through for the launch cadence of the broader commercial space stack, but the equity impact is asymmetric: the direct beneficiary is Blue Origin’s backlog confidence, while ASTS remains the most exposed to schedule slippage because it already lost a payload and now has to rebook orbital access against a tighter timetable. The market tends to underprice how a single upper-stage anomaly can ripple into customer behavior: even if insurance makes ASTS whole on the lost hardware, it does not make up for delayed network deployment, delayed revenue recognition, or the reputational drag of being tied to a reliability incident.

The bigger second-order effect is on launch-provider pricing power. If Blue Origin can demonstrate clean restarts after an FAA review, it strengthens the case that heavy-lift capacity is structurally constrained and that customers will keep paying up for redundancy rather than waiting for a perfectly de-risked provider. That is constructive for the entire space launch supply chain over months, but it also raises the bar for ASTS and similar hardware-dependent names whose economics rely on precise launch timing and low anomaly rates.

Near term, the trade is less about the FAA approval itself than about whether Blue Origin can compress the lost timeline and still hit its stated launch cadence over the next 1-2 quarters. Any additional upper-stage issue would be a credibility hit that likely translates into slower booking momentum and higher effective launch costs for customers. Conversely, a clean re-flight would partially unwind the current discount on ASTS, but only if investors regain confidence that launch risk is manageable rather than recurring.

Consensus may be too focused on the fact that the insurance payout removes the headline loss. What it misses is that insurance does not hedge schedule risk, and schedule risk is the real P&L driver for space-infrastructure names with operating leverage to deployment milestones. The market is likely underestimating how much one successful booster re-flight can benefit Blue Origin’s competitive posture versus the much harder task ASTS faces in restoring investor confidence after a visible mission failure.

Key Decisions for Investors

• Maintain/lean short ASTS into strength for the next 2-6 weeks until Blue Origin demonstrates another clean launch; risk/reward is favorable because the setup is still headline-sensitive and upside is capped by timing uncertainty.
• Consider a relative-value pair: long launch-services exposure versus short ASTS if a listed proxy is available, expressing the view that launch-provider confidence improves faster than satellite-deployment confidence.
• If ASTS sells off again on any follow-on launch commentary, use 1-3 month call spreads instead of stock for a controlled rebound trade; the catalyst is sentiment normalization, but timing remains binary and discrete.
• Watch for a clean New Glenn re-flight as a signal to reduce short exposure in ASTS by 25-50%; a successful restart would likely compress the risk premium quickly over days, not months.
• Avoid chasing broad space enthusiasm here; the better risk/reward is owning the infrastructure enablers with less mission-specific execution risk and fading payload-dependent names until cadence is proven.